EIF4E3 and breast carcinoma: The results showed that the expression levels of AGO2 (Fig. 15A) and EIF4E3 (Fig. 15B) were significantly lower in breast cancer cell lines than in the normal breast cell line, whereas the expression levels of DCPS (Fig. 15C) and EIF4E (Fig. 15D) were significantly higher.